Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's disease

Neurology

Volumn 49, Issue 3, 1997, Pages 890-892

  Rubinsztein, David C ^a   Leggo, J ^a   Chiano, M ^b,e   Korn, S ^a   Dodge, A ^c   Norbury, G ^d   Rosser, E ^d   Craufurd, D ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CILIARY NEUROTROPHIC FACTOR; EXCITOTOXIN; QUINOLINIC ACID;

ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME ANALYSIS; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL;

EID: 0030826134     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.3.890     Document Type: Article

References (10)

1. Hayden MR, Kremer B. Huntington disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic bases of inherited disease. New York: McGraw-Hill, 1995:4483-4510.
2. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1995;56:16-22.
3. Kremer B, Squitieri F, Telenius H, et al. Molecular analysis of late-onset Huntington's disease. J Med Genet 1993;30:991-995.
4. Ranum LPW, Chung M-Y, Banfi S, et al. Molecular and clinical correlations in spinocerebellar ataxia type 1: evidence for familial effects on the age at onset. Am J Hum Genet 1994;55: 244-252.
5. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet 1994;7:79-84.
6. Anderson KD, Panayotatos X, Corcoran TL, Lindsay RM, Wiegand SJ. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci USA 1996;93:7346-7351.
7. Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioural deficits and striatal degeneration in a rodent model of Huntington's disease. J Neurosci 1996;16:5168-5181.
8. Emerich DF, Winn SR, Hantraye PM, et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997;386:395-399.
9. Takahashi R, Kawamura K, Hu J, Hayashi M, Deguchi T. Ciliary neurotrophic factor (CNTF) genotypes and CNTF contents in human sciatic nerves as measured by a sensitive enzyme-linked immunoassay. J Neurochem 1996;67:525-529.
10. Stockli KA, Lillien LE, Naher-Noe M, et al. Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J Cell Biol 1991; 115:447-459.